GeneTex
United States (US)

FGF8 recombinant protein

Cat No. GTX65087

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Application Note

The ED50 as determined by the dose-dependent stimulation of thymidine uptake by BaF3 cells expressing FGF receptors is <0.5 ng/ml, corresponding to a specific activity of >2x10^6 units/mg.

Calculated MW

22.4 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Buffer

10 mM Tris, pH 8.0 + 75 mM NaCl. The protein may appear as a haze or film, which may not be seen at the bottom of the vial.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥95%) and by HPLC.

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Fibroblast Growth Factor8, FGF8, Fibroblast Growth Factor-8, FGF-8b, HBGF, FGF8b, AIGF, FGF 8b, Fibroblast Growth Factor 8

Background

Fibroblast Growth Factor-8 (FGF-8) is also known as Androgen-induced Growth Factor (AIGF), a heparin binding growth factor, which stimulates the proliferation and activation of cells that express the FGF receptors. Recombinant human FGF-8 is a 22.4 kDa protein containing 193 amino acid residues.

Research Area